Eylea For Age-Related Macular Degeneration - Benefit Over Existing Therapy Unclear
The drug aflibercept, under the trade name Eylea, has been approved in Germany since November 2012 for the treatment of wet age-related macular degeneration (AMD).
In an early benefit…